DiscGenics is a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine.
Founders:
Flagg Flanagan
Company Size:
11-50
TechBuzz Articles:
DiscGenics Raises $50 Million for Novel Back Pain Treatment, Mark Tullis, October 21st, 2020
Buzzworthy Mentions:
DiscGenics Announces Positive Interim Data on Clinical Trial of IDCT Therapy, March 4th, 2022
DiscGenics Completes Enrollment in Japanese Study, April 30th, 2021
Our mission is to be a catalyst for the success of the Utah tech and startup ecosystem.
All contents © 2023 IsoTalent Inc. All rights reserved.
TechBuzz is an IsoTalent company
Terms of Use and Privacy Policy
Newsletter - Sign up to receive TechBuzz News daily or weekly